WHO Coronavirus disease (COVID-19) dashboard. COVID 19 Special Issue [Internet]. 2020;10(1). Available from: https://covid19.who.int/.
Post COVID-. 19 condition [Internet]. [cited 2023 Sep 12]. Available from: https://www.who.int/teams/health-care-readiness/post-covid-19-condition.
Mahase E. Covid-19: what do we know about long covid? BMJ. 2020;370:m2815.
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135.
Article CAS PubMed Google Scholar
Cruz Neto J, Frota Cavalcante T, de Carvalho Félix ND. Post-COVID-19 metabolic syndrome: a new challenge for nursing care. Invest Educ Enferm [Internet]. 2023;41(1). https://doi.org/10.17533/udea.iee.v41n1e01.
Lacavalerie MR, Pierre-Francois S, Agossou M, Inamo J, Cabie A, Barnay JL, et al. Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise. Future Cardiol. 2022;18(7):577–84.
Article CAS PubMed Google Scholar
Maamar M, Artime A, Pariente E, Fierro P, Ruiz Y, Gutiérrez S, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901–9.
Article CAS PubMed Google Scholar
Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg Health West Pac. 2023;38:100836.
Article PubMed PubMed Central Google Scholar
Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–73.
Article PubMed PubMed Central Google Scholar
Christensen MC, Loft H, McIntyre RS. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: a novel dual outcome measure in depressive disorders. J Affect Disord. 2018;227:787–94.
Article CAS PubMed Google Scholar
Talmon M, Rossi S, Pastore A, Cattaneo CI, Brunelleschi S, Fresu LG. Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages. Br J Pharmacol. 2018;175(1):113–24.
Article CAS PubMed Google Scholar
Smith J, Browning M, Conen S, Smallman R, Buchbjerg J, Larsen KG, et al. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls. Mol Psychiatry. 2018;23(5):1127–33.
Article CAS PubMed Google Scholar
McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials. Int J Neuropsychopharmacol [Internet]. 2016;19(10). https://doi.org/10.1093/ijnp/pyw055.
Liu CS, Carvalho AF, McIntyre RS. Towards a metabolic subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction. CNS Neurol Disord Drug Targets. 2014;13(10):1693–707.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.
Article CAS PubMed PubMed Central Google Scholar
Samant P, Chavan P, Rai S. TG/HDL-C ratio: a surrogate marker of insulin resistance in patients with metabolic syndrome. MGM J Med Sci. 2014;1(1):18–21.
McIntyre RS. Surrogate markers of insulin resistance in Predicting Major Depressive Disorder: metabolism metastasizes to the brain. Am J Psychiatry. 2021;178(10):885–7.
Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Nasca C, et al. Incident Major Depressive Disorder predicted by three measures of insulin resistance: a Dutch cohort study. Am J Psychiatry. 2021;178(10):914–20.
Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, et al. Association between Mood disorders and Risk of COVID-19 infection, hospitalization, and death: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1079–91.
Article PubMed PubMed Central Google Scholar
McIntyre RS, Phan L, Kwan ATH, Mansur RB, Rosenblat JD, Guo Z, et al. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain [Internet]. 2023 Nov 4. https://doi.org/10.1093/brain/awad377
Makhoul E, Aklinski JL, Miller J, Leonard C, Backer S, Kahar P, et al. A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and Dyslipidemia. Cureus. 2022;14(7):e27438.
PubMed PubMed Central Google Scholar
Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881–95e20.
Article CAS PubMed PubMed Central Google Scholar
Bornstein SR, Cozma D, Kamel M, Hamad M, Mohammad MG, Khan NA, et al. Long-COVID, metabolic and endocrine disease. Horm Metab Res. 2022;54(8):562–6.
Article CAS PubMed PubMed Central Google Scholar
Mansur RB, Brietzke E, McIntyre RS. Is there a metabolic-mood syndrome? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev. 2015;52:89–104.
Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, et al. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromolecular Med. 2011;13(2):93–116.
Article CAS PubMed Google Scholar
Rosenblat JD, McIntyre RS. Are medical comorbid conditions of bipolar disorder due to immune dysfunction? Acta Psychiatr Scand. 2015;132(3):180–91.
Article CAS PubMed Google Scholar
Nguyen JCD, Killcross AS, Jenkins TA. Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci. 2014;8:375.
Article PubMed PubMed Central Google Scholar
Fernández-de-Las-Peñas C, Torres-Macho J, Elvira-Martínez CM, Molina-Trigueros LJ, Sebastián-Viana T, Hernández-Barrera V. Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a multicentre case-control study. Int J Clin Pract. 2021;75(12):e14917.
Petersen A, Bressem K, Albrecht J, Thieß HM, Vahldiek J, Hamm B, et al. The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020;110:154317.
Article CAS PubMed PubMed Central Google Scholar
Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. 2015;16(12):1017–29.
Article CAS PubMed Google Scholar
Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29–35.
Article CAS PubMed Google Scholar
Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm [Internet]. 2010;2010. https://doi.org/10.1155/2010/289645.
Kitzbichler MG, Aruldass AR, Barker GJ, Wood TC, Dowell NG, Hurley SA, et al. Peripheral inflammation is associated with micro-structural and functional connectivity changes in depression-related brain networks. Mol Psychiatry. 2021;26(12):7346–54.
Article PubMed PubMed Central Google Scholar
Duarte JMN. Metabolic alterations Associated to Brain Dysfunction in Diabetes. Aging Dis. 2015;6(5):304–21.
PubMed PubMed Central Google Scholar
Kordestani-Moghadam P, Assari S, Nouriyengejeh S, Mohammadipour F, Pourabbasi A. Cognitive impairments and Associated Structural Brain changes in metabolic syndrome and implications of neurocognitive intervention. J Obes Metab Syndr. 2020;29(3):174–9.
Article PubMed PubMed Central Google Scholar
Nakahachi T, Ishii R, Iwase M, Canuet L, Takahashi H, Kurimoto R, et al. Frontal activity during the digit symbol substitution test determined by multichannel near-infrared spectroscopy. Neuropsychobiology. 2008;57(4):151–8.
留言 (0)